1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Lung Cancer Screening Market – by Technology

1.3.2        North America Lung Cancer Screening Market – by Cancer Type

1.3.3        North America Lung Cancer Screening Market – by Age Group

1.3.4        North America Lung Cancer Screening Market – by End User

1.3.5        North America Lung Cancer Screening Market – by Country

2.           North America Lung Cancer Screening Market –  Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Lung Cancer Screening Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert’s Opinion

5.           North America Lung Cancer Screening Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Lung Cancer Incidences

5.1.2        Increasing Government Support

5.2         Market Restraints

5.2.1        High Cost of Lung Cancer Screening Tests

5.3         Market Opportunities

5.3.1        Structured Lung Cancer Screening Program

5.4         Future Trends

5.4.1        Use of Cutting-Edge Technologies

5.5         Impact Analysis

6.           Lung Cancer Screening Market – North America Analysis

6.1         North America Lung Cancer Screening Market Revenue Forecast and Analysis

7.           North America Lung Cancer Screening Market – Revenue and Forecast to 2028 – By Cancer Type

7.1         Overview

7.2         North America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)

7.3         Non–Small Cell Lung Cancer (NSCLC)

7.3.1        Overview

7.3.2        Non–Small Cell Lung Cancer (NSCLC): North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Mn)

7.4         Small Cell Lung Cancer

7.4.1        Overview

7.4.2        Small Cell Lung Cancer: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

8.           North America Lung Cancer Screening Market Analysis – by Technology

8.1         Overview

8.2         Low-Dose Computed Tomography (LDCT)

8.2.1        Overview

8.2.2        Low-Dose Computed Tomography (LDCT): North America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.3         Chest X-ray

8.3.1        Overview

8.3.2        Chest X-ray: North America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.4         Liquid Biopsy

8.4.1        Overview

8.4.2        Liquid Biopsy: North America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: North America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

9.           North America Lung Cancer Screening Market Analysis – by Age Group

9.1         Overview

9.2 & Older

9.2.1        Overview

9.2.2 & Older: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

9.3         Below 50

9.3.1        Overview

9.3.2        Below 50: North America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.        North America Lung Cancer Screening Market Analysis – by End User

10.1      Overview

10.2      Hospitals

10.2.1     Overview

10.2.2     Hospitals: North America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.3      Diagnostic Centers

10.3.1     Overview

10.3.2     Diagnostic Centers: North America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.4      Others

10.4.1     Overview

10.4.2     Others: North America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

11.        North America Lung Cancer Screening Market – Revenue and Forecast to 2028 – Country Analysis

11.1      North America Lung Cancer Screening Market Overview

11.1.1.1       US: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       US: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.3       US: North America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.1.4       US: North America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.5       US: North America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.1.6       US: North America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.2       Canada: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       Canada: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.3       Canada: North America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.2.4       Canada: North America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.5       Canada: North America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.2.6       Canada: North America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.3       Mexico: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       Mexico: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.3       Mexico: North America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.3.4       Mexico: North America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.5       Mexico: North America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.3.6       Mexico: North America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12.        North America Lung Cancer Screening Market–Industry Landscape

12.1      Recent Growth Strategies

12.1.1     Overview

13.        Company Profiles

13.1      Intelerad Medical Systems

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Nuance Communications Inc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GE HealthCare

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Medtronic

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Canon Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Koninklijke Philips NV

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Siemens AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      CVS Health

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      bioAffinity Technologies, Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   LungLife AI, Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             US North America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 2.             US North America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 3.             US North America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 4.             US North America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 5.             Canada North America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 6.             Canada North America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 7.             Canada North America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 8.             Canada North America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 9.             Mexico North America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 10.          Mexico North America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 11.          Mexico North America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 12.          Mexico North America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13.          Recent Growth Strategies in the North America Lung Cancer Screening Market

Table 14.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Lung Cancer Screening Market Segmentation

Figure 2.           North America Lung Cancer Screening Market, by Country

Figure 3.           North America Lung Cancer Screening Market Overview

Figure 4.           Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in North America Lung Cancer Screening Market

Figure 5.           North America Expected to Show Remarkable Growth During Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           North America Lung Cancer Screening Market Impact Analysis of Driver and Restraints

Figure 9.           North America Lung Cancer Screening Market – Revenue Forecast and Analysis – 2020-2030

Figure 10.        North America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)

Figure 11.        Non–Small Cell Lung Cancer (NSCLC): North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        Small Cell Lung Cancer: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13.        North America Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)

Figure 14.        Low-Dose Computed Tomography (LDCT): North America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 15.        Chest X-ray: North America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 16.        Liquid Biopsy: North America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Others: North America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 18.        North America Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)

Figure 19. & Older: North America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.        Below 50: North America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        North America Lung Cancer Screening Market, by End User, 2022 & 2030 (%)

Figure 22.        Hospitals: North America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.        Diagnostic Centers: North America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24.        Others: North America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        North America Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Million)

Figure 26.        North America Lung Cancer Screening Market Revenue Share, by Key Country, (2022 & 2030)

Figure 27.        US: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 28.        Canada: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        Mexico: North America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)